Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3038|26|3|280-286

ISSN： 0905-6157

Source： PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol.26, Iss.3, 2015-05, pp. : 280-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of an Ultra-Rush Immunotherapy Build-Up Schedule with Therapeutic Vaccines Containing Depigmented and Polymerized Allergen Extracts

By  

International Archives of Allergy and Immunology, Vol. 139, Iss. 2, 2006-02 ,pp. : 153-158

Karger

Access to resources Recommend Favorite

Subcutaneous Immunotherapy with a Depigmented Polymerized Birch Pollen Extract – A New Therapeutic Option for Patients with Atopic Dermatitis

By  

International Archives of Allergy and Immunology, Vol. 155, Iss. 3, 2011-02 ,pp. : 252-256

Karger

Access to resources Recommend Favorite

The Safety of Allergen Specific Sublingual Immunotherapy

By  

Current Drug Safety, Vol. 2, Iss. 2, 2007-05 ,pp. : 117-123

Bentham Science Publishers

Access to resources Recommend Favorite

Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen‐specific basophil response; a real‐life, nonrandomized controlled study

By  

ALLERGY, Vol. 70, Iss. 5, 2015-05 ,pp. : 547-555

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 2, 2015-08 ,pp. : 304-314

John Wiley & Sons Inc

Access to resources Recommend Favorite